ArticlePediatric cardiology2026
Modified Melody Valve Surgical Implantation in Atrioventricular Position in Four Children Under Two Years of Age.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitral and tricuspid valve replacement options have traditionally been limited to mechanical valves, bioprostheses, and the mitral Ross procedure. In recent years, the Melody valve (Medtronic, Minneapolis, MN) has emerged as a viable alternative for infants and young children. We present four patients under two years of age who underwent surgical implantation of a modified Melody valve 22 mm in the atrioventricular position. The valve was placed in the mitral position in three patients and the tricuspid position in one. The procedure was performed with palliative intent in all patients, as no alternative surgical options were available. At the time of valve implantation, two patients were supported with venoarterial extracorporeal membrane oxygenation. At the time of this report, two patients remain alive, with a maximum follow-up of three years in one case following valve implantation. We describe the experience of using a modified Melody valve in the tricuspid or mitral position with palliative intent in four patients, supporting its viability as an option in children under two years of age with limited therapeutic alternatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.